Cancer Vaccines Market
Cancer Vaccines Market by Technology, Treatment Method, Application & Region | Forecast 2023 to 2033
Market Insights on Cancer Vaccines covering sales outlook, demand forecast and up-to-date key trends
Cancer Vaccines Market Snapshot (2023 to 2033)
The global Cancer Vaccines Market is expected to garner a market value of US$ 9 Billion in 2023 and is expected to accumulate a market value of US$ 24.22 Billion by registering a CAGR of 12% in the forecast period 2023 to 2033. The market for Cancer Vaccines registered a CAGR of 9% in the historical period 2018 to 2022.
The Cancer Vaccines market is a segment of the healthcare industry that deals with the effective management of the condition. The Cancer Vaccines market offers a range of vaccines that uses the body's own immune system to recognize and attack cancer cells. There are two main types of cancer vaccines: preventive vaccines and therapeutic vaccines. Preventive vaccines are designed to prevent certain types of cancer, such as the HPV vaccine that helps prevent cervical cancer. Therapeutic vaccines, on the other hand, are designed to treat cancer by stimulating the immune system to recognize and attack cancer cells.
|
Report Attribute |
Details |
|
Expected Market Value (2023) |
US$ 9 Billion |
|
Anticipated Forecast Value (2033) |
US$ 24.22 Billion |
|
Projected Growth Rate (2023 to 2033) |
12% CAGR |
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
2018 to 2022 Cancer Vaccines Market Demand Analysis vs. Forecast 2023 to 2033
According to market research and competitive intelligence provider, Future Market Insights- the market for Cancer Vaccines reflected a value of 9% during the historical period, 2018 to 2022. During this period, the demand for treatment for Cancer increased, driven by factors such as increasing incidence of cancer, growing awareness about cancer prevention and treatment, and technological advancements in vaccine development.
Looking ahead to the period from 2023 to 2033, the cancer vaccines market is expected to continue growing, although at a slightly slower pace than in the previous period. Cancer is expected to remain a major health concern globally, which will drive demand for cancer vaccines. In recent years, several new cancer vaccine options have emerged for Cancer, pushing the market for Cancer Vaccines is expected to register a CAGR of 12% in the forecast period 2023 to 2033.
Which are Some Prominent Drivers of the Cancer Vaccines Market?
Growing advancements in diagnostic and treatment options to push the market growth
The Cancer Vaccines Market is expected to experience significant growth in the coming years, driven by several factors. According to the World Health Organization (WHO), cancer is the second leading cause of death worldwide, responsible for an estimated 9.6 million deaths in 2018. The most common types of cancer worldwide include lung, breast, colorectal, prostate, stomach, and liver cancer.
The increasing prevalence of cancer has led to the development of new technologies such as gene editing and personalized medicine is enabling the development of more effective cancer vaccines. The prevalence of cancer varies by region and demographic group. Low- and middle-income countries are disproportionately affected by cancer, with over 60% of new cancer cases and 70% of cancer deaths occurring in these countries. This is due to a combination of factors including lack of access to prevention and early detection services, limited resources for cancer vaccine, and higher rates of risk factors such as tobacco use and infectious diseases.
Cancer is a major public health concern globally, with millions of new cases diagnosed each year. Overall, the prevalence of cancer is expected to continue to increase globally, with an estimated 29.5 million new cancer cases and 16.5 million cancer deaths expected by 2040, according to the International Agency for Research on Cancer (IARC). The combination of these factors is expected to drive significant growth in the Cancer vaccines market in the coming years.
Find your sweet spots for generating winning opportunities in this market.
What are the Challenges Faced by the Cancer Vaccines Market?
Expensive Cost of Treatment to restrict Market Growth
Cancer is a complex disease, and its nature differs from person to person. As a result, developing a vaccine that can effectively treat all forms of cancer is a major challenge. The current cancer vaccines on the market have limited success rates, and there is a need to develop more effective vaccines to meet the growing demand for cancer treatment.
Many people are not aware of the benefits of cancer vaccines, and this can limit their adoption and use. Furthermore, regulatory challenges can limit the development and approval of new vaccines for Cancer, which can slow down progress in the field. Some people may be resistant to vaccines, and this can limit the effectiveness of cancer vaccines.
Region-Wise Insights
How is the Cancer Vaccines Market Turning Out in the South & East Asia Region?
Increasing Advancements in the Diagnostic Techniques Shaping Landscape for Cancer Vaccines in South & East Asia
The Cancer Vaccines Market in the South and East Asia region is growing, driven by several factors such as increasing cancer incidence, growing awareness about cancer prevention, and the rising demand for personalized medicine are driving the growth of the cancer vaccine market in the region. Additionally, the increasing adoption of advanced technologies such as Next-generation sequencing (NGS) and bioinformatics in cancer research is expected to further fuel market growth.
In South and East Asia, the Cancer Vaccines Market is expected to witness significant growth in the coming years, driven by factors such as increasing cancer incidence, growing demand for innovative treatment options, and rising investments in cancer research and development.
In addition, there is a growing awareness about the disease in the region, which is leading to more frequent diagnoses and better access to vaccines. Governments and healthcare organizations are also taking steps to improve the diagnosis and treatment of Cancer, which is helping to drive growth in the market.
What are the Factors Boosting the Market for Cancer Vaccines in North America?
Increasing Focus on Technological advancements Shaping Landscape for Cancer Vaccines in North America
North America is anticipated to acquire a market share of about 40% in the forecast period. As awareness about cancer vaccines increases among the general population, more people are opting for these vaccines as a preventive measure against cancer. North America has some of the world's leading research institutions, which are dedicated to developing new and effective cancer vaccines. This has led to the development of several innovative cancer vaccines in recent years.
Additionally, The regulatory environment for cancer vaccines in North America is favorable, with regulatory agencies such as the FDA in the USA providing fast-track approval for promising cancer vaccines. Healthcare expenditure in the region is increasing, which has led to increased investment in cancer treatment and prevention, including cancer vaccines.
Get the data you need at a Fraction of the cost
Personalize your report by choosing insights you need
and save 40%!
Category-Wise Insights
By Technology, Which Segment is Likely to Account for a Significant Share?
Recombinant cancer vaccines segment to hold a significant share and push market growth
Currently, the recombinant cancer vaccines segment is expected to account for a significant share of the market. Recombinant cancer vaccines are developed using genetic engineering technology, which enables the production of specific proteins that can stimulate the immune system to attack cancer cells. This technology has shown promising results in clinical trials and has been approved for use in the treatment of certain types of cancer, such as prostate cancer and melanoma.
By Treatment, Which Segment is Likely to Account for a Significant Share?
Therapeutic cancer vaccines to take the lead and drive market growth
Currently, the therapeutic cancer vaccines segment is expected to account for a significant share of the market. Therapeutic cancer vaccines are designed to stimulate the immune system to attack existing cancer cells in patients who have already been diagnosed with cancer. These vaccines are being developed for a variety of cancer types and have shown promising results in clinical trials.
Market Competition
Key players in the market include companies such as Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc, Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Vaccinogen, Inc., F Hoffmann-La Roche AG, and OSE Immunotherapeutics, along with healthcare providers and technology companies among other global players.
- In January 2023, the United kingdom government announced a collaboration with BioNTech, a German company, to trial potential vaccines for cancer and other illnesses, while campaigners cautioned that any breakthrough must remain affordable and accessible. Personalized mRNA therapies, including cancer vaccines that aim to activate the immune system against harmful cells, will be tested on cancer patients in England at both early and late stages. The therapies target active cancer cells and work to prevent their return. BioNTech will establish new research and development centers in the United kingdom, including a laboratory in Cambridge and a headquarters in London, and aim to supply 10,000 therapies to patients from September 2023 until the end of the decade.
The firm developed one of the most widely-distributed Covid-19 vaccines in collaboration with USA pharmaceutical firm Pfizer. The collaboration will cover various cancer types and infectious diseases affecting collectively hundreds of millions of people worldwide.
Report Scope
|
Report Attribute |
Details |
|
Market Value in 2023 |
US$ 9 Billion |
|
Market Value in 2033 |
US$ 24.22 Billion |
|
Growth Rate |
CAGR of 12% from 2023 to 2033 |
|
Base Year for Estimation |
2022 |
|
Historical Data |
2018 to 2022 |
|
Forecast Period |
2023 to 2033 |
|
Quantitative Units |
Revenue in USD Million and CAGR from 2023 to 2033 |
|
Report Coverage |
Revenue Forecast, Volume Forecast, Company Ranking, Competitive Landscape, Growth Factors, Trends and Pricing Analysis |
|
Segments Covered |
|
|
Regions Covered |
|
|
Key Countries Profiled |
|
|
Key Companies Profiled |
Advaxis Inc., Amgen Inc., Dynavax Technologies Corporation, Generex Biotechnology Corporation, GlaxoSmithKline plc, Immunocellular Therapeutics, Ltd, Merck & Co., Inc., Vaccinogen, Inc., F Hoffmann-La Roche AG, and OSE Immunotherapeutics |
|
Customization |
Available Upon Request |
Key Segments Profiled in the Cancer Vaccines Industry Survey
Technology:
- Recombinant Cancer Vaccines
- Whole-cell Cancer Vaccines
- Viral Vector & DNA Cancer Vaccines
- Antigen/Adjuvant Cancer Vaccines
Treatment Method:
- Preventive Vaccine
- Therapeutic Vaccine
Application:
- Prostate Cancer
- Cervical Cancer
- Other Applications
Region:
- North America
- Latin America
- Europe
- East Asia
- South Asia
- Oceania
- Middle East & Africa
Frequently Asked Questions
At what rate did the Cancer Vaccines Market flourish from 2018 to 2022?
From 2018 to 2022, the Cancer Vaccines Market grew at a CAGR of 9%.
What will be the growth rate of the global Cancer Vaccines Market during the forecast period?
The global Cancer Vaccines Market is expected to grow with a 12% CAGR during 2023 to 2033.
What will be the projected market size of the Cancer Vaccines Market by 2033?
As of 2033, the Cancer Vaccines Market is expected to reach US$ 24.22 Billion
Which technology is expected to dominate the global Cancer Vaccines Market during 2033?
According to the FMI analysis, the recombinant cancer vaccines segment accounts for the largest market share.
How is the North America Cancer Vaccines Market projected to grow in 2033?
North America is expected to possess 40% market share for the Cancer Vaccines Market.
How is the Asia Pacific Cancer Vaccines Market projected to grow in 2033?
The Asia Pacific market is projected to increase significantly throughout the forecast period, with a share of 20% during the forecast period.
What is the Expected CAGR from 2023 to 2033?
The market is expected to record a 12% CAGR throughout 2033.
Which Factors will Expand the Market?
Innovations in diagnostics and treatment options are likely to grow the market.
Which Technology type is Estimated to Dominate the Market?
Recombinant cancer vaccines to dominate the market.
What is the Expected Market share of North America in 2033?
North America to acquire a 40% share during the forecast period.
What is the Global Market Projected Value for 2033?
The market is expected to accumulate a value of US$ 24.22 billion by 2033.
Table of Content
1. Executive Summary | Cancer Vaccines Market 1.1. Global Market Outlook 1.2. Demand-side Trends 1.3. Supply-side Trends 1.4. Technology Roadmap Analysis 1.5. Analysis and Recommendations 2. Market Overview 2.1. Market Coverage / Taxonomy 2.2. Market Definition / Scope / Limitations 3. Market Background 3.1. Market Dynamics 3.1.1. Drivers 3.1.2. Restraints 3.1.3. Opportunity 3.1.4. Trends 3.2. Scenario Forecast 3.2.1. Demand in Optimistic Scenario 3.2.2. Demand in Likely Scenario 3.2.3. Demand in Conservative Scenario 3.3. Opportunity Map Analysis 3.4. Investment Feasibility Matrix 3.5. PESTLE and Porter’s Analysis 3.6. Regulatory Landscape 3.6.1. By Key Regions 3.6.2. By Key Countries 3.7. Regional Parent Market Outlook 4. Global Market Analysis 2018 to 2022 and Forecast, 2023 to 2033 4.1. Historical Market Size Value (US$ Million) Analysis, 2018 to 2022 4.2. Current and Future Market Size Value (US$ Million) Projections, 2023 to 2033 4.2.1. Y-o-Y Growth Trend Analysis 4.2.2. Absolute $ Opportunity Analysis 5. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Technology 5.1. Introduction / Key Findings 5.2. Historical Market Size Value (US$ Million) Analysis By Technology, 2018 to 2022 5.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Technology, 2023 to 2033 5.3.1. Recombinant Cancer Vaccines 5.3.2. Whole-cell Cancer Vaccines 5.3.3. Viral Vector & DNA Cancer Vaccines 5.3.4. Antigen/Adjuvant Cancer Vaccines 5.4. Y-o-Y Growth Trend Analysis By Technology, 2018 to 2022 5.5. Absolute $ Opportunity Analysis By Technology, 2023 to 2033 6. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Treatment Method 6.1. Introduction / Key Findings 6.2. Historical Market Size Value (US$ Million) Analysis By Treatment Method, 2018 to 2022 6.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Treatment Method, 2023 to 2033 6.3.1. Preventive Vaccine 6.3.2. Therapeutic Vaccine 6.4. Y-o-Y Growth Trend Analysis By Treatment Method, 2018 to 2022 6.5. Absolute $ Opportunity Analysis By Treatment Method, 2023 to 2033 7. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Application 7.1. Introduction / Key Findings 7.2. Historical Market Size Value (US$ Million) Analysis By Application, 2018 to 2022 7.3. Current and Future Market Size Value (US$ Million) Analysis and Forecast By Application, 2023 to 2033 7.3.1. Prostate Cancer 7.3.2. Cervical Cancer 7.3.3. Other Applications 7.4. Y-o-Y Growth Trend Analysis By Application, 2018 to 2022 7.5. Absolute $ Opportunity Analysis By Application, 2023 to 2033 8. Global Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Region 8.1. Introduction 8.2. Historical Market Size Value (US$ Million) Analysis By Region, 2018 to 2022 8.3. Current Market Size Value (US$ Million) Analysis and Forecast By Region, 2023 to 2033 8.3.1. North America 8.3.2. Latin America 8.3.3. Europe 8.3.4. South Asia 8.3.5. East Asia 8.3.6. Oceania 8.3.7. MEA 8.4. Market Attractiveness Analysis By Region 9. North America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 9.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 9.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 9.2.1. By Country 9.2.1.1. USA 9.2.1.2. Canada 9.2.2. By Technology 9.2.3. By Treatment Method 9.2.4. By Application 9.3. Market Attractiveness Analysis 9.3.1. By Country 9.3.2. By Technology 9.3.3. By Treatment Method 9.3.4. By Application 9.4. Key Takeaways 10. Latin America Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 10.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 10.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 10.2.1. By Country 10.2.1.1. Brazil 10.2.1.2. Mexico 10.2.1.3. Rest of Latin America 10.2.2. By Technology 10.2.3. By Treatment Method 10.2.4. By Application 10.3. Market Attractiveness Analysis 10.3.1. By Country 10.3.2. By Technology 10.3.3. By Treatment Method 10.3.4. By Application 10.4. Key Takeaways 11. Europe Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 11.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 11.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 11.2.1. By Country 11.2.1.1. Germany 11.2.1.2. United kingdom 11.2.1.3. France 11.2.1.4. Spain 11.2.1.5. Italy 11.2.1.6. Rest of Europe 11.2.2. By Technology 11.2.3. By Treatment Method 11.2.4. By Application 11.3. Market Attractiveness Analysis 11.3.1. By Country 11.3.2. By Technology 11.3.3. By Treatment Method 11.3.4. By Application 11.4. Key Takeaways 12. South Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 12.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 12.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 12.2.1. By Country 12.2.1.1. India 12.2.1.2. Malaysia 12.2.1.3. Singapore 12.2.1.4. Thailand 12.2.1.5. Rest of South Asia 12.2.2. By Technology 12.2.3. By Treatment Method 12.2.4. By Application 12.3. Market Attractiveness Analysis 12.3.1. By Country 12.3.2. By Technology 12.3.3. By Treatment Method 12.3.4. By Application 12.4. Key Takeaways 13. East Asia Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 13.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 13.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 13.2.1. By Country 13.2.1.1. China 13.2.1.2. Japan 13.2.1.3. South Korea 13.2.2. By Technology 13.2.3. By Treatment Method 13.2.4. By Application 13.3. Market Attractiveness Analysis 13.3.1. By Country 13.3.2. By Technology 13.3.3. By Treatment Method 13.3.4. By Application 13.4. Key Takeaways 14. Oceania Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 14.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 14.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 14.2.1. By Country 14.2.1.1. Australia 14.2.1.2. New Zealand 14.2.2. By Technology 14.2.3. By Treatment Method 14.2.4. By Application 14.3. Market Attractiveness Analysis 14.3.1. By Country 14.3.2. By Technology 14.3.3. By Treatment Method 14.3.4. By Application 14.4. Key Takeaways 15. MEA Market Analysis 2018 to 2022 and Forecast 2023 to 2033, By Country 15.1. Historical Market Size Value (US$ Million) Trend Analysis By Market Taxonomy, 2018 to 2022 15.2. Market Size Value (US$ Million) Forecast By Market Taxonomy, 2023 to 2033 15.2.1. By Country 15.2.1.1. GCC Countries 15.2.1.2. South Africa 15.2.1.3. Israel 15.2.1.4. Rest of MEA 15.2.2. By Technology 15.2.3. By Treatment Method 15.2.4. By Application 15.3. Market Attractiveness Analysis 15.3.1. By Country 15.3.2. By Technology 15.3.3. By Treatment Method 15.3.4. By Application 15.4. Key Takeaways 16. Key Countries Market Analysis 16.1. USA 16.1.1. Pricing Analysis 16.1.2. Market Share Analysis, 2022 16.1.2.1. By Technology 16.1.2.2. By Treatment Method 16.1.2.3. By Application 16.2. Canada 16.2.1. Pricing Analysis 16.2.2. Market Share Analysis, 2022 16.2.2.1. By Technology 16.2.2.2. By Treatment Method 16.2.2.3. By Application 16.3. Brazil 16.3.1. Pricing Analysis 16.3.2. Market Share Analysis, 2022 16.3.2.1. By Technology 16.3.2.2. By Treatment Method 16.3.2.3. By Application 16.4. Mexico 16.4.1. Pricing Analysis 16.4.2. Market Share Analysis, 2022 16.4.2.1. By Technology 16.4.2.2. By Treatment Method 16.4.2.3. By Application 16.5. Germany 16.5.1. Pricing Analysis 16.5.2. Market Share Analysis, 2022 16.5.2.1. By Technology 16.5.2.2. By Treatment Method 16.5.2.3. By Application 16.6. United kingdom 16.6.1. Pricing Analysis 16.6.2. Market Share Analysis, 2022 16.6.2.1. By Technology 16.6.2.2. By Treatment Method 16.6.2.3. By Application 16.7. France 16.7.1. Pricing Analysis 16.7.2. Market Share Analysis, 2022 16.7.2.1. By Technology 16.7.2.2. By Treatment Method 16.7.2.3. By Application 16.8. Spain 16.8.1. Pricing Analysis 16.8.2. Market Share Analysis, 2022 16.8.2.1. By Technology 16.8.2.2. By Treatment Method 16.8.2.3. By Application 16.9. Italy 16.9.1. Pricing Analysis 16.9.2. Market Share Analysis, 2022 16.9.2.1. By Technology 16.9.2.2. By Treatment Method 16.9.2.3. By Application 16.10. India 16.10.1. Pricing Analysis 16.10.2. Market Share Analysis, 2022 16.10.2.1. By Technology 16.10.2.2. By Treatment Method 16.10.2.3. By Application 16.11. Malaysia 16.11.1. Pricing Analysis 16.11.2. Market Share Analysis, 2022 16.11.2.1. By Technology 16.11.2.2. By Treatment Method 16.11.2.3. By Application 16.12. Singapore 16.12.1. Pricing Analysis 16.12.2. Market Share Analysis, 2022 16.12.2.1. By Technology 16.12.2.2. By Treatment Method 16.12.2.3. By Application 16.13. Thailand 16.13.1. Pricing Analysis 16.13.2. Market Share Analysis, 2022 16.13.2.1. By Technology 16.13.2.2. By Treatment Method 16.13.2.3. By Application 16.14. China 16.14.1. Pricing Analysis 16.14.2. Market Share Analysis, 2022 16.14.2.1. By Technology 16.14.2.2. By Treatment Method 16.14.2.3. By Application 16.15. Japan 16.15.1. Pricing Analysis 16.15.2. Market Share Analysis, 2022 16.15.2.1. By Technology 16.15.2.2. By Treatment Method 16.15.2.3. By Application 16.16. South Korea 16.16.1. Pricing Analysis 16.16.2. Market Share Analysis, 2022 16.16.2.1. By Technology 16.16.2.2. By Treatment Method 16.16.2.3. By Application 16.17. Australia 16.17.1. Pricing Analysis 16.17.2. Market Share Analysis, 2022 16.17.2.1. By Technology 16.17.2.2. By Treatment Method 16.17.2.3. By Application 16.18. New Zealand 16.18.1. Pricing Analysis 16.18.2. Market Share Analysis, 2022 16.18.2.1. By Technology 16.18.2.2. By Treatment Method 16.18.2.3. By Application 16.19. GCC Countries 16.19.1. Pricing Analysis 16.19.2. Market Share Analysis, 2022 16.19.2.1. By Technology 16.19.2.2. By Treatment Method 16.19.2.3. By Application 16.20. South Africa 16.20.1. Pricing Analysis 16.20.2. Market Share Analysis, 2022 16.20.2.1. By Technology 16.20.2.2. By Treatment Method 16.20.2.3. By Application 16.21. Israel 16.21.1. Pricing Analysis 16.21.2. Market Share Analysis, 2022 16.21.2.1. By Technology 16.21.2.2. By Treatment Method 16.21.2.3. By Application 17. Market Structure Analysis 17.1. Competition Dashboard 17.2. Competition Benchmarking 17.3. Market Share Analysis of Top Players 17.3.1. By Regional 17.3.2. By Technology 17.3.3. By Treatment Method 17.3.4. By Application 18. Competition Analysis 18.1. Competition Deep Dive 18.1.1. Advaxis Inc. 18.1.1.1. Overview 18.1.1.2. Product Portfolio 18.1.1.3. Profitability by Market Segments 18.1.1.4. Sales Footprint 18.1.1.5. Strategy Overview 18.1.1.5.1. Marketing Strategy 18.1.2. Amgen Inc. 18.1.2.1. Overview 18.1.2.2. Product Portfolio 18.1.2.3. Profitability by Market Segments 18.1.2.4. Sales Footprint 18.1.2.5. Strategy Overview 18.1.2.5.1. Marketing Strategy 18.1.3. Dynavax Technologies Corporation 18.1.3.1. Overview 18.1.3.2. Product Portfolio 18.1.3.3. Profitability by Market Segments 18.1.3.4. Sales Footprint 18.1.3.5. Strategy Overview 18.1.3.5.1. Marketing Strategy 18.1.4. Generex Biotechnology Corporation 18.1.4.1. Overview 18.1.4.2. Product Portfolio 18.1.4.3. Profitability by Market Segments 18.1.4.4. Sales Footprint 18.1.4.5. Strategy Overview 18.1.4.5.1. Marketing Strategy 18.1.5. GlaxoSmithKline plc 18.1.5.1. Overview 18.1.5.2. Product Portfolio 18.1.5.3. Profitability by Market Segments 18.1.5.4. Sales Footprint 18.1.5.5. Strategy Overview 18.1.5.5.1. Marketing Strategy 18.1.6. Immunocellular Therapeutics, Ltd 18.1.6.1. Overview 18.1.6.2. Product Portfolio 18.1.6.3. Profitability by Market Segments 18.1.6.4. Sales Footprint 18.1.6.5. Strategy Overview 18.1.6.5.1. Marketing Strategy 18.1.7. Merck & Co., Inc. 18.1.7.1. Overview 18.1.7.2. Product Portfolio 18.1.7.3. Profitability by Market Segments 18.1.7.4. Sales Footprint 18.1.7.5. Strategy Overview 18.1.7.5.1. Marketing Strategy 18.1.8. Vaccinogen, Inc. 18.1.8.1. Overview 18.1.8.2. Product Portfolio 18.1.8.3. Profitability by Market Segments 18.1.8.4. Sales Footprint 18.1.8.5. Strategy Overview 18.1.8.5.1. Marketing Strategy 18.1.9. F Hoffmann-La Roche AG 18.1.9.1. Overview 18.1.9.2. Product Portfolio 18.1.9.3. Profitability by Market Segments 18.1.9.4. Sales Footprint 18.1.9.5. Strategy Overview 18.1.9.5.1. Marketing Strategy 18.1.10. OSE Immunotherapeutics 18.1.10.1. Overview 18.1.10.2. Product Portfolio 18.1.10.3. Profitability by Market Segments 18.1.10.4. Sales Footprint 18.1.10.5. Strategy Overview 18.1.10.5.1. Marketing Strategy 19. Assumptions & Acronyms Used 20. Research Methodology
Don't pay for what you don't need
Customize your report by selecting specific countries or regions and save 30%!
List of Tables
Table 1: Global Market Value (US$ Million) Forecast by Region, 2018 to 2033 Table 2: Global Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 3: Global Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 4: Global Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 5: North America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 6: North America Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 7: North America Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 8: North America Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 9: Latin America Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 10: Latin America Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 11: Latin America Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 12: Latin America Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 13: Europe Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 14: Europe Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 15: Europe Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 16: Europe Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 17: South Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 18: South Asia Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 19: South Asia Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 20: South Asia Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 21: East Asia Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 22: East Asia Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 23: East Asia Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 24: East Asia Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 25: Oceania Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 26: Oceania Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 27: Oceania Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 28: Oceania Market Value (US$ Million) Forecast by Application , 2018 to 2033 Table 29: MEA Market Value (US$ Million) Forecast by Country, 2018 to 2033 Table 30: MEA Market Value (US$ Million) Forecast by Technology, 2018 to 2033 Table 31: MEA Market Value (US$ Million) Forecast by Treatment Method, 2018 to 2033 Table 32: MEA Market Value (US$ Million) Forecast by Application , 2018 to 2033
Find your sweet spots for generating winning opportunities in this market.
List of Charts
Figure 1: Global Market Value (US$ Million) by Technology, 2023 to 2033 Figure 2: Global Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 3: Global Market Value (US$ Million) by Application , 2023 to 2033 Figure 4: Global Market Value (US$ Million) by Region, 2023 to 2033 Figure 5: Global Market Value (US$ Million) Analysis by Region, 2018 to 2033 Figure 6: Global Market Value Share (%) and BPS Analysis by Region, 2023 to 2033 Figure 7: Global Market Y-o-Y Growth (%) Projections by Region, 2023 to 2033 Figure 8: Global Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 9: Global Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 10: Global Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 11: Global Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 12: Global Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 13: Global Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 14: Global Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 15: Global Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 16: Global Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 17: Global Market Attractiveness by Technology, 2023 to 2033 Figure 18: Global Market Attractiveness by Treatment Method, 2023 to 2033 Figure 19: Global Market Attractiveness by Application , 2023 to 2033 Figure 20: Global Market Attractiveness by Region, 2023 to 2033 Figure 21: North America Market Value (US$ Million) by Technology, 2023 to 2033 Figure 22: North America Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 23: North America Market Value (US$ Million) by Application , 2023 to 2033 Figure 24: North America Market Value (US$ Million) by Country, 2023 to 2033 Figure 25: North America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 26: North America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 27: North America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 28: North America Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 29: North America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 30: North America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 31: North America Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 32: North America Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 33: North America Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 34: North America Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 35: North America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 36: North America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 37: North America Market Attractiveness by Technology, 2023 to 2033 Figure 38: North America Market Attractiveness by Treatment Method, 2023 to 2033 Figure 39: North America Market Attractiveness by Application , 2023 to 2033 Figure 40: North America Market Attractiveness by Country, 2023 to 2033 Figure 41: Latin America Market Value (US$ Million) by Technology, 2023 to 2033 Figure 42: Latin America Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 43: Latin America Market Value (US$ Million) by Application , 2023 to 2033 Figure 44: Latin America Market Value (US$ Million) by Country, 2023 to 2033 Figure 45: Latin America Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 46: Latin America Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 47: Latin America Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 48: Latin America Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 49: Latin America Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 50: Latin America Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 51: Latin America Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 52: Latin America Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 53: Latin America Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 54: Latin America Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 55: Latin America Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 56: Latin America Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 57: Latin America Market Attractiveness by Technology, 2023 to 2033 Figure 58: Latin America Market Attractiveness by Treatment Method, 2023 to 2033 Figure 59: Latin America Market Attractiveness by Application , 2023 to 2033 Figure 60: Latin America Market Attractiveness by Country, 2023 to 2033 Figure 61: Europe Market Value (US$ Million) by Technology, 2023 to 2033 Figure 62: Europe Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 63: Europe Market Value (US$ Million) by Application , 2023 to 2033 Figure 64: Europe Market Value (US$ Million) by Country, 2023 to 2033 Figure 65: Europe Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 66: Europe Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 67: Europe Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 68: Europe Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 69: Europe Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 70: Europe Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 71: Europe Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 72: Europe Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 73: Europe Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 74: Europe Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 75: Europe Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 76: Europe Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 77: Europe Market Attractiveness by Technology, 2023 to 2033 Figure 78: Europe Market Attractiveness by Treatment Method, 2023 to 2033 Figure 79: Europe Market Attractiveness by Application , 2023 to 2033 Figure 80: Europe Market Attractiveness by Country, 2023 to 2033 Figure 81: South Asia Market Value (US$ Million) by Technology, 2023 to 2033 Figure 82: South Asia Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 83: South Asia Market Value (US$ Million) by Application , 2023 to 2033 Figure 84: South Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 85: South Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 86: South Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 87: South Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 88: South Asia Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 89: South Asia Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 90: South Asia Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 91: South Asia Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 92: South Asia Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 93: South Asia Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 94: South Asia Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 95: South Asia Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 96: South Asia Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 97: South Asia Market Attractiveness by Technology, 2023 to 2033 Figure 98: South Asia Market Attractiveness by Treatment Method, 2023 to 2033 Figure 99: South Asia Market Attractiveness by Application , 2023 to 2033 Figure 100: South Asia Market Attractiveness by Country, 2023 to 2033 Figure 101: East Asia Market Value (US$ Million) by Technology, 2023 to 2033 Figure 102: East Asia Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 103: East Asia Market Value (US$ Million) by Application , 2023 to 2033 Figure 104: East Asia Market Value (US$ Million) by Country, 2023 to 2033 Figure 105: East Asia Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 106: East Asia Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 107: East Asia Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 108: East Asia Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 109: East Asia Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 110: East Asia Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 111: East Asia Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 112: East Asia Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 113: East Asia Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 114: East Asia Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 115: East Asia Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 116: East Asia Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 117: East Asia Market Attractiveness by Technology, 2023 to 2033 Figure 118: East Asia Market Attractiveness by Treatment Method, 2023 to 2033 Figure 119: East Asia Market Attractiveness by Application , 2023 to 2033 Figure 120: East Asia Market Attractiveness by Country, 2023 to 2033 Figure 121: Oceania Market Value (US$ Million) by Technology, 2023 to 2033 Figure 122: Oceania Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 123: Oceania Market Value (US$ Million) by Application , 2023 to 2033 Figure 124: Oceania Market Value (US$ Million) by Country, 2023 to 2033 Figure 125: Oceania Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 126: Oceania Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 127: Oceania Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 128: Oceania Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 129: Oceania Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 130: Oceania Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 131: Oceania Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 132: Oceania Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 133: Oceania Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 134: Oceania Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 135: Oceania Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 136: Oceania Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 137: Oceania Market Attractiveness by Technology, 2023 to 2033 Figure 138: Oceania Market Attractiveness by Treatment Method, 2023 to 2033 Figure 139: Oceania Market Attractiveness by Application , 2023 to 2033 Figure 140: Oceania Market Attractiveness by Country, 2023 to 2033 Figure 141: MEA Market Value (US$ Million) by Technology, 2023 to 2033 Figure 142: MEA Market Value (US$ Million) by Treatment Method, 2023 to 2033 Figure 143: MEA Market Value (US$ Million) by Application , 2023 to 2033 Figure 144: MEA Market Value (US$ Million) by Country, 2023 to 2033 Figure 145: MEA Market Value (US$ Million) Analysis by Country, 2018 to 2033 Figure 146: MEA Market Value Share (%) and BPS Analysis by Country, 2023 to 2033 Figure 147: MEA Market Y-o-Y Growth (%) Projections by Country, 2023 to 2033 Figure 148: MEA Market Value (US$ Million) Analysis by Technology, 2018 to 2033 Figure 149: MEA Market Value Share (%) and BPS Analysis by Technology, 2023 to 2033 Figure 150: MEA Market Y-o-Y Growth (%) Projections by Technology, 2023 to 2033 Figure 151: MEA Market Value (US$ Million) Analysis by Treatment Method, 2018 to 2033 Figure 152: MEA Market Value Share (%) and BPS Analysis by Treatment Method, 2023 to 2033 Figure 153: MEA Market Y-o-Y Growth (%) Projections by Treatment Method, 2023 to 2033 Figure 154: MEA Market Value (US$ Million) Analysis by Application , 2018 to 2033 Figure 155: MEA Market Value Share (%) and BPS Analysis by Application , 2023 to 2033 Figure 156: MEA Market Y-o-Y Growth (%) Projections by Application , 2023 to 2033 Figure 157: MEA Market Attractiveness by Technology, 2023 to 2033 Figure 158: MEA Market Attractiveness by Treatment Method, 2023 to 2033 Figure 159: MEA Market Attractiveness by Application , 2023 to 2033 Figure 160: MEA Market Attractiveness by Country, 2023 to 2033
Recommendations
Explore Healthcare Insights
View Reports
